MBBC
Marathon Bancorp, Inc.
MBBC has the edge over MS overall, supported by stronger valuation and stronger fundamentals.
MS
Morgan Stanley
MS's outlook is improving, though it still trails on the overall score.
MBBC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MBBC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MBBC.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
MBBC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 23x | $14.90 | — |
| Cheap | 35x | $22.80 | +53% |
| Fair | 55x | $35.52 | +138% |
| Expensive | 155x | $101 | +575% |
Historical ranges are pointers, not guarantees.
MBBC has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
MBBC Forward outlook
There aren't enough analyst estimates for MBBC to show an outlook.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
MBBC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.65 | +829% |
| Q2 2026 | $0.66 | +$0.69 |
| Q1 2026 | $0.37 | +118% |
| Q4 2025 | $0.24 | +$0.34 |
| Q3 2025 | $0.07 | +$0.10 |
| Q2 2025 | -$0.03 | +$0.04 |
| Q1 2025 | $0.17 | +143% |
| Q4 2024 | -$0.10 | -124% |
MBBC earned $0.65 per share over the past year, about nine times what it earned the year before.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over MBBC on earnings, with more consistent year-over-year improvement.
MBBC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.5M | +16% |
| Q2 2026 | $2.3M | +22% |
| Q1 2026 | $2.3M | +38% |
| Q4 2025 | $2.2M | +42% |
| Q3 2025 | $2.1M | +33% |
| Q2 2025 | $1.9M | +23% |
| Q1 2025 | $1.7M | +7.6% |
| Q4 2024 | $1.6M | -4.6% |
MBBC's revenue has grown year over year for seven quarters in a row: $2M last quarter, up 16% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | -2.6 points |
| Q2 2026 | 17% | +40 points |
| Q1 2026 | 26% | +15 points |
| Q4 2025 | 26% | +23 points |
| Q3 2025 | 26% | +12 points |
| Q2 2025 | -23% | -27 points |
| Q1 2025 | 12% | +65 points |
| Q4 2024 | 3.3% | -11 points |
MBBC's operating margin was 23% last quarter, down 2.6 points from the same quarter a year ago.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS's revenue has grown year over year for 14 quarters in a row: $20.3B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS has the edge over MBBC on profitability, with a higher operating margin.
MBBC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.6M | +242% |
| Q2 2026 | $54.1K | +$584.3K |
| Q1 2026 | $110.1K | -86% |
| Q4 2025 | $1.4M | +1233% |
| Q3 2025 | $456.6K | -50% |
| Q2 2025 | -$530.3K | -353% |
| Q1 2025 | $773.2K | +$1.8M |
| Q4 2024 | $105K | -62% |
MBBC has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
MBBC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.9% | +52.8K shares |
| 1 year | +3.4% | +91.6K shares |
| 3 years | -4% | -116K shares |
| 5 years | -5.4% | -158K shares |
MBBC has 3M diluted shares, up 3.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $148,875 |
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over MBBC on shareholder dilution, with a more favorable share count trend.
MBBC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.3x | Healthy |
| Q2 2026 | 7.0x | High |
| Q1 2026 | 13.8x | High |
| Q4 2025 | 14.3x | High |
| Q3 2025 | 19.7x | High |
| Q2 2025 | 41.7x | High |
| Q1 2025 | 16.6x | High |
| Q1 2024 | 34.2x | High |
MBBC has the edge over MS on leverage, with a lower net debt burden relative to earnings.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
MBBC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.4 | Neutral |
| Stochastic | 47.1 | Neutral |
MBBC's weekly RSI is 53 (neutral) and its Stochastic is 47 (neutral).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
MBBC PE vs Financial Services Sector
| Metric | MBBC | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 13x | 76% above |
| PE % | 11 | 19 | 8 pts below |
MBBC is trading at 23x earnings, a 76% premium to the Financial Services sector's median of 13x.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS has the edge over MBBC on valuation relative to its sector.
MBBC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $14.9 | 0.3% above |
| 20 week MA | $15.0 | 0.7% below |
| 50 week MA | $14.1 | 5.4% above |
MBBC has stronger trend alignment. MBBC is above 2 of 3 weekly averages versus MS above 3 of 5.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
MBBC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $7.49 | $12.2 | +63% |
| 2026 YTD | $12.2 | $14.9 | +22% |
MBBC has the edge over MS on returns for 2026, with the stronger performance.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has finished higher in five of the last six years. It's up 4% so far in 2026.